• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction

    2/28/25 4:48:00 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email

    Cross Country Healthcare, Inc. ("Cross Country" or the "Company") (NASDAQ:CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare.

    As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ.

    Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission.

    BofA Securities, Inc. is serving as financial advisor and Davis Polk & Wardwell LLP is serving as legal advisor to Cross Country.

    About Cross Country Healthcare

    Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience and insight. We help clients tackle complex labor-related challenges and achieve high-quality outcomes, while reducing complexity and improving visibility through data-driven insights.

    Copies of this and other press releases, as well as additional information about Cross Country Healthcare, can be accessed online at ir.crosscountry.com. Stockholders and prospective investors can also register to automatically receive Cross Country Healthcare's press releases, filings with the Securities and Exchange Commission (SEC), and other notices by e-mail.

    Forward Looking Statements

    This communication contains "forward-looking statements" within the Private Securities Litigation Reform Act of 1995. Any statements contained in this communication that are not statements of historical fact, including statements regarding the transaction contemplated by the Agreement and Plan of Merger between the Company, Aya and certain of Aya's subsidiaries (the "Merger", and such agreement, the "Merger Agreement"), including the expected timing and closing of the proposed Merger; the Company's ability to consummate the proposed Merger; the expected benefits of the proposed Merger and other considerations taken into account by the Board in approving the proposed Merger; the amounts to be received by stockholders and expectations for the Company prior to and following the closing of the proposed Merger, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management's current expectations for the future of the Company based on current expectations and assumptions relating to the Company's business, the economy and other future conditions. Forward-looking statements generally can be identified through the use of words such as "believes," "anticipates," "may," "should," "will," "plans," "projects," "expects," "expectations," "estimates," "forecasts," "predicts," "targets," "prospects," "strategy," "signs," and other words of similar meaning in connection with the discussion of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others: (i) the timing to consummate the proposed Merger, (ii) the risk that a condition of closing of the proposed Merger may not be satisfied or that the closing of the proposed Merger might otherwise not occur, (iii) the risk that a regulatory approval that may be required for the proposed Merger is not obtained or is obtained subject to conditions that are not anticipated, (iv) the diversion of management time on transaction-related issues, (v) risks related to disruption of management time from ongoing business operations due to the proposed Merger, (vi) the risk that any announcements relating to the proposed Merger could have adverse effects on the market price of the common stock of the Company, (vii) the risk that the proposed Merger and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with its suppliers and customers, (viii) the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the Merger Agreement, including in circumstances requiring the Company to pay a termination fee, (ix) the risk that competing offers will be made; (x) unexpected costs, charges or expenses resulting from the Merger, (xi) potential litigation relating to the Merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto, (xii) worldwide economic or political changes that affect the markets that the Company's businesses serve which could have an effect on demand for the Company's services and impact the Company's profitability, (xiii) effects from global pandemics, epidemics or other public health crises, (xiv) changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement and customer needs, and (xv) disruptions in the global credit and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs and trade restrictions, cyber-security vulnerabilities, foreign currency volatility, swings in consumer confidence and spending, costs of providing services, retention of key employees, and outcomes of legal proceedings, claims and investigations. Accordingly, actual results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and in the Company's other filings with the SEC. The list of factors is not intended to be exhaustive.

    These forward-looking statements speak only as of the date of this communication, and the Company does not assume any obligation to update or revise any forward-looking statement made in this communication or that may from time to time be made by or on behalf of the Company.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250228992806/en/

    Investors

    Josh Vogel, Vice President, Investor Relations

    561-237-8310

    [email protected]



    Media

    Jim Golden / Clayton Erwin

    Collected Strategies

    [email protected]

    Get the next $CCRN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    10/5/2022$36.00Buy → Hold
    Truist
    2/24/2022$33.00 → $42.00Buy
    Benchmark
    1/27/2022$18.00 → $27.00Hold → Buy
    Jefferies
    More analyst ratings

    $CCRN
    Financials

    Live finance-specific insights

    See more
    • Cross Country Healthcare Announces First Quarter 2025 Financial Results

      Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87   % Diluted EPS $ (0.02 )   $ (0.10 )

      5/7/25 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Wednesday, November 6, 2024

      Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the

      10/18/24 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Announces Second Quarter 2024 Financial Results

      Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771       (37 ) %   (10 ) % Gross profit margin*   20.8   %   (200 ) bps   40   bps Net (loss) income attributable to common stockh

      7/31/24 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      11/13/24 9:39:57 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      11/13/24 4:36:10 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      2/13/24 5:02:31 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cross Country Healthcare Announces First Quarter 2025 Financial Results

      Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87   % Diluted EPS $ (0.02 )   $ (0.10 )

      5/7/25 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction

      Cross Country Healthcare, Inc. ("Cross Country" or the "Company") (NASDAQ:CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ. Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exch

      2/28/25 4:48:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

      Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

      12/4/24 7:45:00 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Group President, Delivery Krug Marc S. covered exercise/tax liability with 5,649 shares, decreasing direct ownership by 14% to 34,853 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:44:41 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Chief Financial Officer Burns William J. covered exercise/tax liability with 13,465 shares, decreasing direct ownership by 5% to 242,508 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:43:42 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • General Counsel and Secretary Ball Susan E covered exercise/tax liability with 9,386 shares, decreasing direct ownership by 5% to 176,032 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:43:08 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Cross Country Healthcare Inc.

      SCHEDULE 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      5/9/25 12:24:57 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Cross Country Healthcare Inc.

      10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

      5/7/25 4:45:32 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

      5/7/25 4:28:50 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cross Country downgraded by Barrington Research

      Barrington Research downgraded Cross Country from Outperform to Mkt Perform

      12/10/24 9:21:19 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • JMP Securities initiated coverage on Cross Country

      JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform

      12/6/23 7:33:30 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country downgraded by Jefferies with a new price target

      Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously

      11/3/23 7:41:51 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cash W Larry bought $61,320 worth of shares (6,000 units at $10.22), increasing direct ownership by 3% to 199,632 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      12/31/24 5:15:10 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Leadership Updates

    Live Leadership Updates

    See more
    • Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

      Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

      12/4/24 7:45:00 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • The Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600

      NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1.  S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda

      9/26/24 6:04:00 PM ET
      $CCRN
      $CHK
      $ENSG
      $SITC
      Professional Services
      Consumer Discretionary
      Oil & Gas Production
      Energy
    • Cross Country Healthcare Appoints Phillip Noe as Chief Information Officer

      Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin

      5/10/21 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary